Soleno Therapeutics, Inc.
← Back to SLNO Overview

Soleno Therapeutics, Inc. (SLNO)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

13.95

Financial Fundamentals

SLNOQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2013-03-316.70
2013-06-30-3.15
2013-09-30-4.27
2013-12-31-6.98
2014-03-31-8.15
2014-06-30-2.43
2014-09-30-2.71
2014-12-31-1.61
2015-03-31-4.78
2015-06-3014.05
2015-09-30-8.04
2015-12-31-12.03
2016-03-31-6.90
2016-06-30-6.41
2016-09-30-6.45
2016-12-31-10.40
2017-03-31-7.82
2017-06-30-7.52
2017-09-30-8.30
2017-12-31-8.74
2018-03-31-11.81
2018-06-30-7.79
2018-09-30-22.28
2018-12-31213.75
2019-03-31-10.90
2019-06-30-10.73
2019-09-3062.50
2019-12-31-10.21
2020-03-31-22.88
2020-06-30-17.34
2020-09-30-28.52
2020-12-31-60.31
2021-03-31-14.32
2021-06-30-10.18
2021-09-30-11.34
2021-12-31-14.50
2022-03-31-3.91
2022-06-30-4.83
2022-09-30-3.21
2022-12-31-4.27
2023-03-31-3.04
2023-06-30-6.62
2023-09-30-7.77
2023-12-31-23.40
2024-03-31-17.58
2024-06-30-18.55
2024-09-30-6.90
2024-12-31-8.85
2025-03-31-18.80
2025-06-30-224.49
2025-09-3034.49
2025-12-3112.06
2026-03-3113.95

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.

Soleno Therapeutics, Inc. (SLNO) P/E Ratio History & Valuation Cycles